Download PDF
Allgemeinmedizin up2date 2021; 02(04): 311-322
DOI: 10.1055/a-1388-4103
Symptome - Syndrome

Akuter und chronischer Husten – Differenzialdiagnose und Behandlung

Felix Holzinger
1   Institut für Allgemeinmedizin, Charité - Universitätsmedizin Berlin, Berlin, Deutschland
,
Sabine Gehrke-Beck
,
Karen Krüger
› Author Affiliations
› Further Information
Also available at
    Permissions and Reprints All articles of this category

Husten ist ein häufiger Konsultationsgrund in der hausärztlichen Praxis. Meist ist das Symptom harmlos und selbstlimitierend wie z.B. bei einem banalen Erkältungshusten – jedoch können auch schwerwiegende Erkrankungen wie Malignome die Ursache sein. Die Abklärung ist daher nicht immer einfach. Dieser Beitrag stellt ein gezieltes und angemessenes Vorgehen dar und diskutiert, welche Behandlungen empfohlen und effektiv sind.

Schlüsselwörter

akuter Husten - chronischer Husten - Hausarztpraxis - Differenzialdiagnose


Publication History

Article published online:
09 November 2021

© 2021. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • Literatur

  • 1 Laux G, Rosemann T, Körner T. et al. Detailed data collection regarding the utilization of medical services, morbidity, course of illness and outcomes by episode-based documentation in general practices within the CONTENT project. Gesundheitswesen 2007; 69: 284-291
    Thieme ConnectPubMedSearch in Google Scholar
  • 2 Chung KF, Pavord ID. Prevalence, pathogenesis, and causes of chronic cough. Lancet 2008; 371: 1364-1374
    CrossrefPubMedSearch in Google Scholar
  • 3 Bundesanstalt für Arbeitsschutz und Arbeitsmedizin (BAuA). Volkswirtschaftliche Kosten durch Arbeitsunfähigkeit 2018. https://www.baua.de/DE/Themen/Arbeitswelt-und-Arbeitsschutz-im-Wandel/Arbeitsweltberichterstattung/Kosten-der-AU/Kosten-der-Arbeitsunfaehigkeit_node.html [2021–05–20]
  • 4 Krüger K, Gehrke-Beck S, Holzinger F. et al. S3 Leitlinie akuter und chronischer Husten der Deutschen Gesellschaft für Allgemeinmedizin und Familienmedizin (DEGAM). 2021
    PubMedSearch in Google Scholar
  • 5 Altiner A, Wilm S, Däubener W. et al. Sputum colour for diagnosis of a bacterial infection in patients with acute cough. Scand J Prim Health Care 2009; 27: 70-73
    CrossrefPubMedSearch in Google Scholar
  • 6 van der Meer V, Neven AK, van den Broek PJ. et al. Diagnostic value of C reactive protein in infections of the lower respiratory tract: systematic review. BMJ (Clinical research ed) 2005; 331: 26
    CrossrefPubMedSearch in Google Scholar
  • 7 van Vugt SF, Broekhuizen BDL, Lammens C. et al. Use of serum C reactive protein and procalcitonin concentrations in addition to symptoms and signs to predict pneumonia in patients presenting to primary care with acute cough: diagnostic study. BMJ 2013; 346: f2450
    CrossrefPubMedSearch in Google Scholar
  • 8 Holm A, Pedersen SS, Nexoe J. et al. Procalcitonin versus C-reactive protein for predicting pneumonia in adults with lower respiratory tract infection in primary care. Br J Gen Pract 2007; 57: 555-560
    PubMedSearch in Google Scholar
  • 9 Huang Y, Chen R, Wu T. et al. Association between point-of-care CRP testing and antibiotic prescribing in respiratory tract infections: a systematic review and meta-analysis of primary care studies. Br J Gen Pract 2013; 63: e787-e794
    CrossrefPubMedSearch in Google Scholar
  • 10 Schuetz P, Wirz Y, Sager R. et al. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. Cochr Data Syst Rev 2017; 10: Cd007498
    CrossrefPubMedSearch in Google Scholar
  • 11 Wood F, Brookes-Howell L, Hood K. et al. A multi-country qualitative study of clinicians' and patients' views on point of care tests for lower respiratory tract infection. Fam Pract 2011; 28: 661-669
    CrossrefPubMedSearch in Google Scholar
  • 12 Smith SM, Fahey T, Smucny J. et al. Antibiotics for acute bronchitis. 2017;
    CrossrefPubMedSearch in Google Scholar
  • 13 Sierocinski E, Holzinger F. Ivy leaf (Hedera helix) for acute upper respiratory tract infections: an updated systematic review. Eur J Clin Pharmacol 2021; 77: 1113-1122
    CrossrefPubMedSearch in Google Scholar
  • 14 Matthys H, de Mey C, Carls C. et al. Efficacy and tolerability of myrtol standardized in acute bronchitis. A multi-centre, randomised, double-blind, placebo-controlled parallel group clinical trial vs. cefuroxime and ambroxol. Arzneimittelforschung 2000; 50: 700-711
    Thieme ConnectPubMedSearch in Google Scholar
  • 15 Kemmerich B, Eberhardt R, Stammer H. Efficacy and tolerability of a fluid extract combination of thyme herb and ivy leaves and matched placebo in adults suffering from acute bronchitis with productive cough. A prospective, double-blind, placebo-controlled clinical trial. Arzneimittelforschung 2006; 56: 652-660
    Thieme ConnectPubMedSearch in Google Scholar
  • 16 Spurling GK, Del Mar CB, Dooley L. et al. Delayed antibiotic prescriptions for respiratory infections. Cochr Data Syst Rev 2017; 9: Cd004417
    CrossrefPubMedSearch in Google Scholar
  • 17 Coxeter P, Del Mar CB, McGregor L. et al. Interventions to facilitate shared decision making to address antibiotic use for acute respiratory infections in primary care. Cochr Data Syst Rev 2015; 2015: Cd010907
    CrossrefPubMedSearch in Google Scholar
  • 18 McNally M, Curtain J, O'Brien KK. et al. Validity of British Thoracic Society guidance (the CRB-65 rule) for predicting the severity of pneumonia in general practice: systematic review and meta-analysis. Br J Gen Pract 2010; 60: e423-433
    CrossrefPubMedSearch in Google Scholar
  • 19 Ewig S, Kolditz M, Pletz M. et al. Leitlinie Behandlung von erwachsenen Patienten mit ambulant erworbener Pneumonie – Update 2021. 2021
    PubMedSearch in Google Scholar
  • 20 Irwin RS, French CL, Chang AB. et al. Classification of Cough as a Symptom in Adults and Management Algorithms: CHEST Guideline and Expert Panel Report. Chest 2018; 153: 196-209
    CrossrefPubMedSearch in Google Scholar
  • 21 Smith JA, Kitt MM, Morice AH. et al. Gefapixant, a P2X3 receptor antagonist, for the treatment of refractory or unexplained chronic cough: a randomised, double-blind, controlled, parallel-group, phase 2b trial. Lancet Resp Med 2020; 8: 775-785
    CrossrefPubMedSearch in Google Scholar